These mutations, albeit prevalent, are not present in all cases of pediatric BCR-ABL+ B-ALL10,59 suggesting that B-ALL transformation depends on an intermediate leukemogenic process independent of gene deletions. This evidence concerns the gene ABL1 and acute lymphoblastic leukemia.